Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Applying GAN-based data augmentation to improve transcriptome-based prognostication in breast cancer

Cristiano Guttà, Christoph Morhard, View ORCID ProfileMarkus Rehm
doi: https://doi.org/10.1101/2022.10.07.22280776
Cristiano Guttà
1Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: markus.morrison{at}izi.uni-stuttgart.de cristiano.gutta{at}izi.uni-stuttgart.de
Christoph Morhard
2ProKanDo GmbH, Elfriede-Breitenbach-Straße 38a, 71640 Ludwigsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Rehm
1Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany
3Stuttgart Research Center Systems Biology, University of Stuttgart, Nobelstrasse 15, 70569 Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Markus Rehm
  • For correspondence: markus.morrison{at}izi.uni-stuttgart.de cristiano.gutta{at}izi.uni-stuttgart.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Established prognostic tests based on limited numbers of transcripts can identify high-risk breast cancer patients yet are approved only for individuals presenting with specific clinical features or disease characteristics. Deep learning algorithms could hold potential for stratifying patient cohorts based on full transcriptome data, yet the development of robust classifiers is hampered by the number of variables in omics datasets typically far exceeding the number of patients. To overcome this hurdle, we propose a classifier based on a data augmentation pipeline consisting of a Wasserstein generative adversarial network (GAN) with gradient penalty and an embedded auxiliary classifier to obtain a trained GAN discriminator (T-GAN-D). Applied to 1244 patients of the METABRIC breast cancer cohort, this classifier outperformed established breast cancer biomarkers in separating low- from high-risk patients (disease specific death, progression or relapse within 10 years from initial diagnosis). Importantly, the T-GAN-D also performed across independent, merged transcriptome datasets (METABRIC and TCGA-BRCA cohorts), and merging data improved overall patient stratification. In conclusion, GAN-based data augmentation therefore allowed generating a robust classifier capable of stratifying low- vs high-risk patients based on full transcriptome data and across independent and heterogeneous breast cancer cohorts.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MR and CG receive funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy - EXC 2075 - 390740016 and acknowledge the support by the Stuttgart Center for Simulation Science (SimTech).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used only openly available human data that were originally available through cBioportal.org, the R package MetaGxBreast (Gendoo et al. 2019, DOI: 10.1038/s41598-019-45165-4) and the following publications: Xia et al. 2019 (DOI: 10.1038/s41467-019-13588-2); Rueda et al. 2019 (DOI: 10.1038/s41586-019-1007-8); Liu et al. 2018 (DOI: 10.1016/j.cell.2018.02.052).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Transcriptome data (median Z-scores), OS, DSS and associated clinical records of the METABRIC cohort were downloaded from cbioportal.org. Locoregional and distant recurrence records and ROR-P scores of the MB cohort were retrieved from Rueda et al. 2019 (DOI: 10.1038/s41586-019-1007-8) and Xia et al. 2019 (DOI: 10.1038/s41467-019-13588-2) respectively. Clinical records, OS, DSS and PFI of the TCGA-BRCA cohort were integrated from cBioportal.org and Liu et al. 2018 (DOI: 10.1016/j.cell.2018.02.052). Curated METABRIC and BRCA-TCGA expression data were downloaded using the MetaGxBreast R package (Gendoo et al. 2019, DOI: 10.1038/s41598-019-45165-4). The input files and scripts used to generate the results are available in the Zenodo repository (DOI: 10.5281/zenodo.7151831).

https://zenodo.org/record/7151831

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 08, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Applying GAN-based data augmentation to improve transcriptome-based prognostication in breast cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Applying GAN-based data augmentation to improve transcriptome-based prognostication in breast cancer
Cristiano Guttà, Christoph Morhard, Markus Rehm
medRxiv 2022.10.07.22280776; doi: https://doi.org/10.1101/2022.10.07.22280776
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Applying GAN-based data augmentation to improve transcriptome-based prognostication in breast cancer
Cristiano Guttà, Christoph Morhard, Markus Rehm
medRxiv 2022.10.07.22280776; doi: https://doi.org/10.1101/2022.10.07.22280776

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)